Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 348 of 1,261
  1. US 10988465

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  2. US 10988458

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  3. US 10988453

    Compositions comprising an urolithin compound

    Amazentis SA · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  4. US 10988475

    Agonists of the apelin receptor and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  5. US 10988472

    Compounds and method for blocking transmission of malarial parasite

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  6. US 10988441

    Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

    Valo Early Discovery, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  7. US 10988537

    Antibodies comprising chimeric constant domains

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  8. US 10987434

    Detection and treatment of caries and microcavities with nanoparticles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  9. US 10987405

    Method of reducing formation of etanercept aggregates or fragments

    Coherus BioSciences, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  10. US 10987499

    Swallowable drug delivery device and method of delivery

    Rani Therapeutics, LLC · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  11. US 10987373

    DNA origami nanostructures for treatment of acute kidney injury

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  12. US 10987360

    Hepatitis B core protein modulators

    ASSEMBLY BIOSCIENCES, INC. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  13. US 10987358

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  14. US 10987348

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  15. US 10987310

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Jazz Pharmaceuticals, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  16. US 10987346

    Iloperidone for the treatment of schizophrenia

    VANDA PHARMACEUTICALS INC. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  17. US 10988448

    Therapeutic compounds and compositions

    Agios Pharmaceuticals, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  18. US 10987333

    Methods and compositions for preventing and treating auditory dysfunctions

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  19. US 10987336

    Method of preventing or treating side effect of tumor therapy

    ONQUALITY PHARMACEUTICALS CHINA LTD. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  20. US 10987385

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Finch Therapeutics Holdings LLC · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  21. US 10988450

    3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

    Valo Early Discovery, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  22. US 10987399

    Stable formulations for parenteral injection of peptide drugs

    XERIS PHARMACEUTICALS, INC. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  23. US 10987354

    Inhibitors of influenza virus replication and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  24. US 10988733

    Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissue

    China Medical University · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.